ANGLE plc (LON:AGL – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 15.97 ($0.20) and traded as low as GBX 14.05 ($0.18). ANGLE shares last traded at GBX 14.25 ($0.18), with a volume of 210,410 shares.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank restated a “buy” rating and set a GBX 70 ($0.89) target price on shares of ANGLE in a report on Wednesday, April 24th.
ANGLE Price Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- How to Use the MarketBeat Dividend Calculator
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Are Penny Stocks a Good Fit for Your Portfolio?
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- How to buy stock: A step-by-step guide for beginners
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.